## Diagnosis: Warm Autoimmune Hemolytic Anemia (AIHA) The clinical presentation and positive DAT confirm immune-mediated hemolysis. The next step is to characterize the antibody involved. ### Why Flow Cytometry with Anti-IgG and Anti-IgM is Correct **Key Point:** Flow cytometry using monoclonal antibodies against specific immunoglobulin classes (IgG, IgM, IgA) directly identifies which antibody class is coating the red cells. - In warm AIHA (most common), **IgG** is the predominant antibody - In cold agglutinin disease, **IgM** is typically involved - Flow cytometry provides **quantitative and qualitative** data on antibody class and complement deposition - This information guides management (e.g., splenectomy is more effective in IgG-mediated disease) **High-Yield:** Flow cytometry is the **gold standard** for antibody characterization in DAT-positive hemolysis and is superior to tube-based methods in sensitivity and specificity. ### Investigation Comparison Table | Investigation | Purpose | Specificity | Clinical Use | | --- | --- | --- | --- | | **Flow cytometry (anti-IgG/IgM)** | Identify antibody class on RBC surface | High | Classify AIHA subtype, guide therapy | | Indirect antiglobulin test (IAT) | Detect free antibodies in serum | Moderate | Screening, not classification | | Elution test | Recover antibodies from RBC surface | Moderate | Identify antibody specificity (alloimmunization) | | Osmotic fragility | Assess RBC membrane integrity | Low | Hereditary spherocytosis, not immune hemolysis | **Clinical Pearl:** Warm AIHA with IgG antibodies has a better prognosis with splenectomy (~80% response) compared to IgM-mediated disease.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.